|
|
|
|
LEADER |
01397nam a2200265 u 4500 |
001 |
EB001892034 |
003 |
EBX01000000000000001055181 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200301 r ||| eng |
020 |
|
|
|a 9781473133754
|
245 |
0 |
0 |
|a Prostate cancer
|h Elektronische Ressource
|b diagnosis and management
|c National Institute for Health and Care Excellence
|
260 |
|
|
|a London
|b National Institute for Health and Care Excellence
|c 9 May 2019, 2019
|
300 |
|
|
|a 1 PDF file (51 pages)
|
653 |
|
|
|a Prostatic Neoplasms / diagnosis
|
653 |
|
|
|a Neoplasm Staging
|
653 |
|
|
|a Prostatic Neoplasms / therapy
|
710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
740 |
0 |
2 |
|a Prostate cancer (National Collaborating Centre for Cancer : 2014)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a NICE guideline
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK544759
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer
|